<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03111407</url>
  </required_header>
  <id_info>
    <org_study_id>CSE2012-05K</org_study_id>
    <nct_id>NCT03111407</nct_id>
  </id_info>
  <brief_title>iAssist vs. Conventional Instrumentation in Total Knee Arthroplasty</brief_title>
  <official_title>Evaluation of Zimmer® iASSIST™ vs. Conventional Instrumentation in Total Knee Arthroplasty: Radiographic, Clinical and Economic Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer, GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this prospective study is to evaluate Zimmer® iASSIST™ with respect to&#xD;
      radiographic, clinical and economic outcomes and compared to conventional instrumentation in&#xD;
      primary total knee arthroplasty (NexGen or Persona knee implants).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study design is a prospective, multicenter, comparative outcome study. The study requires&#xD;
      each site to obtain IRB (Institutional Review Board) approval prior to study enrollment. All&#xD;
      potential study subjects will be required to participate in the Informed Consent Process.&#xD;
&#xD;
      All study subjects will undergo preoperative clinical evaluations prior to their total knee&#xD;
      arthroplasty. Investigators will collect clinical data for 12 months. Follow-up clinical&#xD;
      visits include 3 and 12 months post-operatively.&#xD;
&#xD;
      The primary endpoint of this study is defined as component alignment as determined using long&#xD;
      leg X-Rays. The secondary endpoint will be to evaluate the Knee Society Score, EQ-5D&#xD;
      (EuroQol-5Dimensions) scoring system, operating room time, blood loss and complications&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2014</start_date>
  <completion_date type="Actual">December 2018</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>2 groups of patients: 1 will have the knee prosthesis implanted with iAssist and the other with conventional instrumentation.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Study patients will not know if their knee prosthesis will be implanted with iAssist or with conventional instrumentation</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Component Alignment</measure>
    <time_frame>1 year</time_frame>
    <description>Assess the differences in component alignment, measured by the mean of radiographs, between iASSIST™ and conventional instrumentation in primary total knee arthroplasty (TKA) procedures.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knee Society Score Assessment</measure>
    <time_frame>1 year</time_frame>
    <description>Assess the differences in Knee Society Score between iASSIST™ and conventional instrumentation in primary TKA procedures. Higher (and better) score value: 100, lower value: 0.&#xD;
Score 80-100 = Excellent Score 70-79 = Good Score 60-69 = Fair Score below 60 = Poor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee Society Score Function</measure>
    <time_frame>1 year</time_frame>
    <description>Knee Society Score function asses 12 months postoperatively between iASSIST™ and conventional instrumentation in primary TKA procedures. Higher (and better) score value: 100, lower value: 0.&#xD;
Score 80-100 = Excellent Score 70-79 = Good Score 60-69 = Fair Score below 60 = Poor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D Questionnaire</measure>
    <time_frame>1 year</time_frame>
    <description>Assess the differences in EQ-5D between iASSIST™ and conventional instrumentation in primary TKA procedures at 12 months postoperatively.&#xD;
Comparison of the derived EQ-5D scale and health state between the 2 groups. The EQ-5D questionnaire includes five dimensions (5D): mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.&#xD;
EQ-5D values range from -0.2 to 1 where the negative values correspond to bad health states (states worse than death), and 1.0 corresponds to perfect health.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Avascular Necrosis</condition>
  <condition>Post-traumatic; Arthrosis</condition>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>iAssist group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients will have primary total knee arthroplasty with the iAssist. The iAssist Knee System is a computer assisted stereotaxic surgical instrument system to assist the surgeon in the positioning of orthopedic implant system components intra-operatively. It involves surgical instruments and position sensors to determine alignment axes in relation to anatomical landmarks and to precisely position alignment instruments and implant components relative to these axes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional instrumentation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients will have primary total knee arthroplasty with the conventional instrumentation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>total knee arthroplasty</intervention_name>
    <description>surgical procedure in which damaged parts of the knee joint are replaced with an implant.</description>
    <arm_group_label>conventional instrumentation</arm_group_label>
    <arm_group_label>iAssist group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is male or female&#xD;
&#xD;
          -  Patient needs a primary total knee replacement using the NexGen LPS Flex or Persona&#xD;
             knee implant&#xD;
&#xD;
          -  Patient is diagnosed with non-inflammatory degenerative joint disease (e.g.,&#xD;
             osteoarthritis, post-traumatic arthritis, avascular necrosis, etc.)&#xD;
&#xD;
          -  Patient is over 18 years old&#xD;
&#xD;
          -  Patient is able to:&#xD;
&#xD;
               -  Understand what participation in the study entails and willing to consent&#xD;
                  (patient or his/her legal guardian) to participate in the study by signing and&#xD;
                  dating an IRB/EC (ethics committee) approved inform consent form, and&#xD;
&#xD;
               -  Follow surgeon/staff instructions, and&#xD;
&#xD;
               -  Return for all follow-up evaluations, and&#xD;
&#xD;
               -  Able and willing to undergo a preoperative full-leg, standing radiographs and/or&#xD;
                  CT-scan&#xD;
&#xD;
          -  Patient meets an acceptable preoperative medical clearance and is free of or treated&#xD;
             for cardiac, pulmonary, hematological or other conditions that would pose excessive&#xD;
             operative risk.&#xD;
&#xD;
          -  Patient has a presence of varus or valgus deformity of 15 degrees or less.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient is currently enrolled in an investigational new drug or device study.&#xD;
&#xD;
          -  Patient has an active infection (including septic knee, distant infection, or&#xD;
             osteomyelitis).&#xD;
&#xD;
          -  Patient has severe hip arthrosis.&#xD;
&#xD;
          -  Patient has neurological disorders (including, but not limited to Parkinson's&#xD;
             disease).&#xD;
&#xD;
          -  Patient has had a prior ipsilateral unicompartmental knee arthroplasty, TKA, knee&#xD;
             fusion or patellectomy.&#xD;
&#xD;
          -  Patient has hip or knee ankylosis.&#xD;
&#xD;
          -  Patient has inflammatory joint disease.&#xD;
&#xD;
          -  Patient has rheumatoid knee arthritis.&#xD;
&#xD;
          -  Patient has indications of intra- and/or extra-articular deformations that would&#xD;
             eliminate or tend to eliminate adequate implant support or prevent the use of an&#xD;
             appropriately sized implant, such as polio, history of tibial plateau fracture, etc.&#xD;
&#xD;
          -  Patient has any metal within 150 mm of the joint line for the operative-side knee.&#xD;
&#xD;
          -  Patient has knee deformities greater than 15 degrees of fixed varus, valgus, or&#xD;
             flexion contracture on initial physical examination.&#xD;
&#xD;
          -  Female who is pregnant or lactating.&#xD;
&#xD;
          -  Patient currently involved in any personal injury litigation, medical-legal or&#xD;
             worker's compensation claims.&#xD;
&#xD;
          -  Patient has arterial disease or stents that would exclude the use of a tourniquet.&#xD;
&#xD;
          -  Patient has insufficient quality or quantity of bone to support the implant due to&#xD;
             prior knee surgery (or surgeries), cancer, metabolic bone disease,&#xD;
             osteoporosis/osteopenia (diagnosed or treated with medication), active/old/remote&#xD;
             infection, etc.&#xD;
&#xD;
          -  Patient has a mental condition that may interfere with his/her ability to give an&#xD;
             informed consent or interfere with his/her ability or willingness to fulfill the&#xD;
             requirements of the study.&#xD;
&#xD;
          -  Patient has a condition that would place excessive demands on the implant (e.g.,&#xD;
             Charcot's joints, muscle deficiencies, multiple joint disabilities, skeletal&#xD;
             immaturity, etc.).&#xD;
&#xD;
          -  Patient has collateral ligament insufficiency.&#xD;
&#xD;
          -  Patient has an immunosuppressive disorder (e.g., AIDS, etc.) that would require&#xD;
             cytotoxic drugs, corticosteroids, large dose of irradiation, or antilymphocytic serum.&#xD;
&#xD;
          -  Patient has an existing condition that would, in the opinion of the investigator,&#xD;
             compromise participation or follow-up in this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paola Vivoda, Ass.Direct</last_name>
    <role>Study Director</role>
    <affiliation>Zimmer Biomet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital El Angel, S.A.</name>
      <address>
        <city>Malaga</city>
        <zip>29007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Unviersitario Son Espases</name>
      <address>
        <city>Palma de Mallorca</city>
        <zip>07010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Balgrist</name>
      <address>
        <city>Zurich</city>
        <zip>8008</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 6, 2017</study_first_submitted>
  <study_first_submitted_qc>April 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <results_first_submitted>June 9, 2020</results_first_submitted>
  <results_first_submitted_qc>March 18, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 13, 2021</results_first_posted>
  <last_update_submitted>March 18, 2021</last_update_submitted>
  <last_update_submitted_qc>March 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>primary total knee arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 12, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/07/NCT03111407/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>75 patients were intended to be enrolled according to the protocol but only 72 were finally enrolled.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>iAssist Group</title>
          <description>45 iASSIST cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
        </group>
        <group group_id="P2">
          <title>Conventional Instrumentation Group</title>
          <description>27 conventional instrumentation cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>iAssist Group</title>
          <description>45 iASSIST cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
        </group>
        <group group_id="B2">
          <title>Conventional Instrumentation Group</title>
          <description>27 conventional cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="45"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="72"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="72"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.3" spread="7.9"/>
                    <measurement group_id="B2" value="70.3" spread="7.4"/>
                    <measurement group_id="B3" value="68.4" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="72"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight kg</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="72"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81.4" spread="17.2"/>
                    <measurement group_id="B2" value="84.3" spread="13.0"/>
                    <measurement group_id="B3" value="82.5" spread="15.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI) kg/m^2</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="72"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.4" spread="5.5"/>
                    <measurement group_id="B2" value="30.7" spread="4.6"/>
                    <measurement group_id="B3" value="30.5" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height cm</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="45"/>
                    <count group_id="B2" value="27"/>
                    <count group_id="B3" value="72"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="163.5" spread="10.6"/>
                    <measurement group_id="B2" value="166.0" spread="9.6"/>
                    <measurement group_id="B3" value="164.5" spread="10.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Component Alignment</title>
        <description>Assess the differences in component alignment, measured by the mean of radiographs, between iASSIST™ and conventional instrumentation in primary total knee arthroplasty (TKA) procedures.</description>
        <time_frame>1 year</time_frame>
        <population>Available data of enrolled patients were used for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>iAssist Group</title>
            <description>45 iASSIST cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
          </group>
          <group group_id="O2">
            <title>Conventional Instrumentation Group</title>
            <description>27 conventional cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
          </group>
        </group_list>
        <measure>
          <title>Component Alignment</title>
          <description>Assess the differences in component alignment, measured by the mean of radiographs, between iASSIST™ and conventional instrumentation in primary total knee arthroplasty (TKA) procedures.</description>
          <population>Available data of enrolled patients were used for analysis.</population>
          <units>degree</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="179" spread="2.9"/>
                    <measurement group_id="O2" value="178" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Hip Knee Angle value 1 year post surgery: Mean+/- SD (N)(Min, Max) 95%C.I (lower, upper)&#xD;
iAssist group: 179.9 +/-2.9 (44) (171, 185.3)&#xD;
Conventional group: 178.9 +/-3.9 (26) (167, 185)</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Data analyzed with SAS Enterprise Guided (version 7.15 HF3, SAS lnstitute lnc., Cary, NC). Significance level set with q = 0.05. Continuous data (e.g. age, weight, EQ-5D) were summarized using mean, standard deviation, minimum, median, maximum and number of observations. Comparison between continuous baseline and patient visits were performed using standard statistical tests (e.g., a t-test, Wilcoxon test, or one-way ANOVA (as appropriate) were performed as required to evaluate the difference).</non_inferiority_desc>
            <p_value>0.2342</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Knee Society Score Assessment</title>
        <description>Assess the differences in Knee Society Score between iASSIST™ and conventional instrumentation in primary TKA procedures. Higher (and better) score value: 100, lower value: 0.&#xD;
Score 80-100 = Excellent Score 70-79 = Good Score 60-69 = Fair Score below 60 = Poor</description>
        <time_frame>1 year</time_frame>
        <population>Available data of enrolled patients were used for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>iAssist Group</title>
            <description>45 iASSIST cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
          </group>
          <group group_id="O2">
            <title>Conventional Instrumentation Group</title>
            <description>27 conventional cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
          </group>
        </group_list>
        <measure>
          <title>Knee Society Score Assessment</title>
          <description>Assess the differences in Knee Society Score between iASSIST™ and conventional instrumentation in primary TKA procedures. Higher (and better) score value: 100, lower value: 0.&#xD;
Score 80-100 = Excellent Score 70-79 = Good Score 60-69 = Fair Score below 60 = Poor</description>
          <population>Available data of enrolled patients were used for analysis.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.7" spread="12.5"/>
                    <measurement group_id="O2" value="72.4" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Knee Society Score Assessment 1 year post surgery: Mean+/- SD (N)(Min, Max) 95%C.I (lower, upper)&#xD;
iAssist group: 74.7 +/- 12.5 [44] (30.2, 78.0, 89.5), 95% C.I. (70.9, 78.5)&#xD;
Conventional group: 72.4 +/- 11.6 [26] (45.0, 75.2, 90.1), 95% C.I. (67.7, 77.1)</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Data analyzed with SAS Enterprise Guided (version 7.15 HF3, SAS lnstitute lnc., Cary, NC). Significance level set with q = 0.05. Continuous data (e.g. age, weight, EQ-5D) were summarized using mean, standard deviation, minimum, median, maximum and number of observations. Comparison between continuous baseline and patient visits were performed using standard statistical tests (e.g., a t-test, Wilcoxon test, or one-way ANOVA (as appropriate) were performed as required to evaluate the difference).</non_inferiority_desc>
            <p_value>0.4427</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Knee Society Score Function</title>
        <description>Knee Society Score function asses 12 months postoperatively between iASSIST™ and conventional instrumentation in primary TKA procedures. Higher (and better) score value: 100, lower value: 0.&#xD;
Score 80-100 = Excellent Score 70-79 = Good Score 60-69 = Fair Score below 60 = Poor</description>
        <time_frame>1 year</time_frame>
        <population>Available data of enrolled patients were used for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>iAssist Group</title>
            <description>45 iASSIST cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
          </group>
          <group group_id="O2">
            <title>Conventional Instrumentation Group</title>
            <description>27 conventional cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
          </group>
        </group_list>
        <measure>
          <title>Knee Society Score Function</title>
          <description>Knee Society Score function asses 12 months postoperatively between iASSIST™ and conventional instrumentation in primary TKA procedures. Higher (and better) score value: 100, lower value: 0.&#xD;
Score 80-100 = Excellent Score 70-79 = Good Score 60-69 = Fair Score below 60 = Poor</description>
          <population>Available data of enrolled patients were used for analysis.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.5" spread="13.8"/>
                    <measurement group_id="O2" value="78.5" spread="19.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Knee Soceity Score Function 1 year post surgery: Mean+/- SD (N)(Min, Max) 95%C.I (lower, upper) iAssist group: 80.5 +/- 13.8 [44] (55.0, 80.0, 100.0), 95% C.I. (76.2, 84.7) Conventional group: 78.5 +/- 19.1 [26] (40.0, 80.0, 100.0),95% C.I. (70.8, 86.2)</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Data analyzed with SAS Enterprise Guided (version 7.15 HF3, SAS lnstitute lnc., Cary, NC). Significance level set with q = 0.05. Continuous data (e.g. age, weight, EQ-5D) were summarized using mean, standard deviation, minimum, median, maximum and number of observations. Comparison between continuous baseline and patient visits were performed using standard statistical tests (e.g., a t-test, Wilcoxon test, or one-way ANOVA (as appropriate) were performed as required to evaluate the difference).</non_inferiority_desc>
            <p_value>0.6154</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>EQ-5D Questionnaire</title>
        <description>Assess the differences in EQ-5D between iASSIST™ and conventional instrumentation in primary TKA procedures at 12 months postoperatively.&#xD;
Comparison of the derived EQ-5D scale and health state between the 2 groups. The EQ-5D questionnaire includes five dimensions (5D): mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.&#xD;
EQ-5D values range from -0.2 to 1 where the negative values correspond to bad health states (states worse than death), and 1.0 corresponds to perfect health.</description>
        <time_frame>1 year</time_frame>
        <population>Available data of enrolled patients were used for analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>iAssist Group</title>
            <description>45 iASSIST cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
          </group>
          <group group_id="O2">
            <title>Conventional Instrumentation Group</title>
            <description>27 conventional instrumentation cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
          </group>
        </group_list>
        <measure>
          <title>EQ-5D Questionnaire</title>
          <description>Assess the differences in EQ-5D between iASSIST™ and conventional instrumentation in primary TKA procedures at 12 months postoperatively.&#xD;
Comparison of the derived EQ-5D scale and health state between the 2 groups. The EQ-5D questionnaire includes five dimensions (5D): mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.&#xD;
EQ-5D values range from -0.2 to 1 where the negative values correspond to bad health states (states worse than death), and 1.0 corresponds to perfect health.</description>
          <population>Available data of enrolled patients were used for analysis.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="0.2"/>
                    <measurement group_id="O2" value="0.8" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>EQ-5D score 1 year post surgery: Mean+/- SD (N)(Min, Max) 95%C.I (lower, upper) iAssist group: 0.8 +/- 0.2 [29] (0.0, 1.0, 1.0), 95% C.I. (0.7, 0.9) Conventional group: 0.8 +/- 0.3 [20] (0.1, 0.8, 1.0), 95% C.I. (0.7, 0.9)</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Data analyzed with SAS Enterprise Guided (version 7.15 HF3, SAS lnstitute lnc., Cary, NC). Significance level set with q = 0.05. Continuous data (e.g. age, weight, EQ-5D) were summarized using mean, standard deviation, minimum, median, maximum and number of observations. Comparison between continuous baseline and patient visits were performed using standard statistical tests (e.g., a t-test, Wilcoxon test, or one-way ANOVA (as appropriate) were performed as required to evaluate the difference).</non_inferiority_desc>
            <p_value>0.4549</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The adverse events were collected preoperatively, intraoperatively and postoperatively (at 3 months ±2 weeks and 12 months ±1 month postoperative).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>iAssist Group</title>
          <description>45 iASSIST cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
        </group>
        <group group_id="E2">
          <title>Conventional Instrumentation Group</title>
          <description>27 conventional cases have been enrolled in 3 sites between April 2014 and August 2017.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Lump in the neck: metastasis,as well as in the lungs</sub_title>
                <description>treated by removal and irradiation.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Sepsis in bronchial asthma, infection exacerbation</sub_title>
                <description>treated with antibiotics and cortisone</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Poor alignment in tibia component</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>Implant failure</sub_title>
                <description>treated by total knee revision.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>Patella transverse fracture+dislocation of the prosthesis+tibia shaft fracture+infe</sub_title>
                <description>adverse events occured in the opposite side (left side).</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <description>treated with Anticoagulation</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic reaction after eating nuts</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>Allergic reaction unclear cause (itching, dyspnea, rash)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>Flexion Contracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>Allergic reaction (Dafalgan)</sub_title>
                <description>treated by stopping the drugs and giving zavegyl/zantic</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Fall from the bed</sub_title>
                <description>Patient and the knee were ok.</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>patient felt on the floor, he wanted to stand up alone</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Radius fracture</sub_title>
                <description>treated by surgery</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <description>treated by surgery 1 year later</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>Delayed Wound Healing</sub_title>
                <description>treated by wound revision and surgery</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>Patient still had a joint effusion 6 months after surgery</sub_title>
                <description>treated by joint puncture</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Pain in the calf (deep vein thrombosis)</sub_title>
                <description>treated with xarelto 10mg/day for 3 month</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Since the first follow-up visits were performed according to the standard of care of each site, they did not occur at the same time point.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Emilie Rohmer, Clinical Operations Manager</name_or_title>
      <organization>Zimmer Biomet</organization>
      <phone>+41 58 85 48210</phone>
      <email>Emilie.Rohmer@zimmerbiomet.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

